Literature DB >> 27859443

Metabolic characterization of the early stage of hepatic fibrosis in rat using GC-TOF/MS and multivariate data analyses.

Hui Jiang1,2, Jun-Mei Song1, Peng-Fei Gao3, Xiu-Juan Qin1, Shuang-Zhi Xu1, Jia-Fu Zhang1.   

Abstract

The aim of this study was to explore the changes in the urine metabolic spectrum in rats with the early stage of liver fibrosis using gas chromatography-time of flight/mass spectrometry (GC-TOF/MS), try to search for potential biomarkers and elucidate the probably metabonomic pathogenesis. The early stage of liver fibrosis was established with a single subcutaneous injection of carbon tetrachloride twice each week for 4 weeks continuously. At the end of the experiment, GC-TOF/MS technology with multivariate statistical approaches such as principal component analysis, partial least squares-discriminant analysis and orthogonal partial least squares-discriminant analysis was used to analyze the changes in the metabolic spectrum trajectory and identify potential biomarkers. Twelve potential biomarkers in the model group, such as succinic acid, threonine and lactose, were selected, which indicate that the metabonomic pathogenesis of the early stage of liver fibrosis may be related to disorders of energy metabolism, amino acid metabolism and fatty acid metabolism.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  GC-TOF/MS; metabolomics; potential biomarker; the early stage of liver fibrosis; urine

Mesh:

Substances:

Year:  2017        PMID: 27859443     DOI: 10.1002/bmc.3899

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  6 in total

Review 1.  Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology.

Authors:  Ming-Ling Chang; Sien-Sing Yang
Journal:  Cells       Date:  2019-11-12       Impact factor: 6.600

2.  A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis.

Authors:  Chang Fan; Fu Rong Wu; Jia Fu Zhang; Hui Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-12       Impact factor: 2.629

3.  Screening and evaluation of key genes in contributing to pathogenesis of hepatic fibrosis based on microarray data.

Authors:  Furong Wu; Lijuan Ning; Ran Zhou; Aizong Shen
Journal:  Eur J Med Res       Date:  2020-09-17       Impact factor: 2.175

Review 4.  Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?

Authors:  Maria Martin-Grau; Vannina G Marrachelli; Daniel Monleon
Journal:  World J Hepatol       Date:  2022-02-27

5.  Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach.

Authors:  Hong Chang; Hong-Yu Meng; Shu-Min Liu; Yu Wang; Xiao-Xu Yang; Fang Lu; Hong-Yu Wang
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

6.  Proteomic landscape of TGF-β1-induced fibrogenesis in renal fibroblasts.

Authors:  Shujun Zhou; Xiaoke Yin; Manuel Mayr; Mazhar Noor; Peter J Hylands; Qihe Xu
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.